Why Adial Pharmaceuticals Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket

Gainers

• Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) rose 64.6% to $0.6912 in pre-market trading after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
• Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 42.2% to $0.2474 in pre-market trading after jumping around 35% on Monday.
• PaxMedica, Inc. (NASDAQ:PXMD) shares rose 16.3% to $1.93 in pre-market trading after dropping 10% on Monday.
• Nyxoah S.A. (NASDAQ:NYXH) rose 13.7% to $6.07 in pre-market trading. Nyxoah, on Monday, said it has completed all 115 implants in its DREAM U.S. pivotal study, submitted the first module in the modular PMA submission and implanted the first patient in the ACCCESS U.S. pivotal study.
• Southland Holdings, Inc. (NYSE:SLND) rose 13.3% to $10.43 in pre-market trading after gaining around 14% on Monday.
• ATA Creativity Global (NASDAQ:AACG) shares rose 12.8% to $2.20 in pre-market trading. ATA Creativity, during November, posted a rise in quarterly sales.
• Troika Media Group, Inc. (NASDAQ:TRKA) rose 12.7% to $0.8627 in pre-market trading after surging more than 48% on Monday.
• Ecoark Holdings, Inc. (NASDAQ:ZEST) rose 10% to $0.22 in pre-market trading after gaining more than 4% on Monday.
• Exela Technologies, Inc. (NASDAQ:XELA) shares rose 7.6% to $0.0688 in pre-market trading after dropping 7% on Monday. Exela Technologies announced updates to 2023 operational performance improvement objectives.
• Catalyst Biosciences, Inc. (NASDAQ:CBIO) rose 7.1% to $0.2570 in pre-market trading. GC Biopharma recently signed an Asset Purchase Agreement with the company.

Losers

• Cara Therapeutics, Inc. (NASDAQ:CARA) fell 30.6% to $6.94 in pre-market after the company posted downbeat Q4 results.
• Freight Technologies, Inc. (NASDAQ:FRGT) fell 19.1% to $0.2299 in pre-market trading after dropping more than 5% on Monday.
• Ambrx Biopharma Inc. (NYSE:AMAM) shares dropped 15.5% to $10.60 in pre-market trading. Ambrx shares jumped 95% on Monday after the company announced its transfer from the NYSE to the Nasdaq.
• Appreciate Holdings, Inc. (NASDAQ:SFR) fell 15.4% to $2.59 in pre-market trading after jumping over 159% on Monday.
• Tremor International Ltd (NASDAQ:TRMR) fell 10.1% to $6.79 in pre-market trading following 2022 results.
• Microvast Holdings, Inc. (NASDAQ:MVST) shares fell 8.2% to $1.23 in pre-market trading. Microvast Holdings is expected toreport its consolidated financial results for the fourth quarter of 2022 on March 16, 2023.
• Entera Bio Ltd. (NASDAQ:ENTX) shares fell 7.6% to $1.33 in pre-market trading after jumping 42% on Monday.
• Nutanix, Inc. (NASDAQ:NTNX) fell 7.5% to $26.57 in pre-market trading after the company reported preliminary second-quarter results and issued third-quarter guidance.
• Gamida Cell Ltd. (NASDAQ:GMDA) fell 6% to $1.57 in pre-market trading.
• Rivian Automotive, Inc. (NASDAQ:RIVN) fell 6% to $16.10 in pre-market trading. Rivian announced late on Monday that it intends to offer $1.3 billion worth of green convertible senior notes due 2029 in a private placement to qualified institutional buyers.

Now Read This: Top 5 Utilities Stocks That Could Blast Off In March